A Study to Evaluate Renal Allograft Fibrosis by MRI

Overview

About this study

The purpose of this study is to validate an MRI method to detect renal fibrosis in patients after kidney transplantation (KT).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • We will recruit 20 men and women.
  • 18-80 years of age.
  • Any race or ethnicity.
  • Scheduled for surveillance kidney biopsies 4 years (n=10) or 7 years (n=10) after living donor KT for end-stage kidney disease.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Lilach Lerman, M.D., Ph.D.

Contact us for the latest status

Contact information:

Beverly Tietje C.S.T.

(507) 255-0401

Tietje.Beverly@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20493369

Mayo Clinic Footer